The RUNX1 gene helps guide how blood stem cells develop into platelets and other blood cells. If it does not work properly, you may have low platelets, easy bruising, nosebleeds, or heavier bleeding, and some people also have a higher chance of blood cancers such as leukemia. This gene plays an important role in keeping blood cell growth organized. Certain variants in the RUNX1 gene can cause an inherited platelet condition linked to myeloid leukemia.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or manage processes in the body. Some genes contain the directions for producing proteins, the active parts of cells. Other genes mainly help determine when certain processes happen, where they take place, and how strongly they occur. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. More on this topic is available in the LearnHub.
Overview
RUNX1Gene function
What if the gene works
The RUNX1 gene helps control how blood stem cells grow and mature in the bone marrow. It is especially important for making healthy platelets and supporting normal blood cell development.
Risk
What if the gene does not work
Pathogenic variants in the RUNX1 gene often disrupt blood cell development, causing lifelong low platelets and easy bruising or bleeding. Milder and more severe variants can differ in effect, and some raise the chance of leukemia.
Treatment
What does that mean for your treatment
No RUNX1-specific drug treatment is currently established. If a blood cancer develops, a pathogenic variant in the RUNX1 gene can affect management by shaping bone marrow transplant planning, especially avoiding related donors who carry the same familial variant. RUNX1 is also being studied as a biomarker and treatment target in leukemia.
Conditions associated with RUNX1
Gene function
What if the gene works
In bone marrow, the RUNX1 gene helps blood cells develop in an organized way. It gives cells timing signals so they know when to grow, mature, or specialize. Understanding how the RUNX1 gene helps make blood cells also explains why it matters for everyday health.
The RUNX1 gene acts like a switchboard for many other genes in developing blood cells. Its protein attaches to DNA and helps turn the right genes on or off at the right time.
This gene supports the step by step formation of blood cells from early stem cells in the bone marrow. It helps these young cells move toward specific roles instead of staying immature.
RUNX1 helps guide cells called megakaryocytes, which are the large bone marrow cells that release platelets into the blood. This supports normal platelet production as part of routine blood cell renewal.
The RUNX1 gene also helps direct the development of some white blood cells. By guiding these cells as they mature, it supports normal immune system function.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
To understand how variants in the RUNX1 gene influence its function, it helps to know that some changes make the protein unstable, while others weaken how it grips DNA or works with partner proteins. Milder variants may leave some activity, but more severe loss-of-function variants can reduce control of blood-forming genes to a greater degree. This often relates to stronger effects on platelet problems and, in some families, an earlier or higher chance of blood cancer.
How variants are linked to conditions
Pathogenic variants in the RUNX1 gene cause familial platelet disorder with associated myeloid malignancy, an inherited RUNX1 gene condition marked by easy bruising or bleeding and a higher chance of blood cancers. People often have low platelets or platelets that do not work well. The risk is highest for myelodysplastic syndrome and acute myeloid leukemia, and some families also have acute lymphoblastic leukemia.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely present in the general population. Most do not have a direct effect on health and instead represent normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
With RUNX1, risk is driven mainly by the gene change itself, especially for lifelong low platelets and a higher chance of certain blood cancers. Age and extra DNA changes that build up in blood cells over time can affect whether cancer develops. There is not enough evidence to say lifestyle changes clearly lower this inherited risk.
Inheritance of RUNX1 variants
For people looking into how RUNX1 variants are inherited, the best established pattern is autosomal dominant. This means a parent with a disease-causing variant in the RUNX1 gene has a 50% chance of passing it to each child, regardless of sex. In families with RUNX1-related platelet conditions and a higher chance of certain blood cancers, the variant can pass from a mother or father to sons or daughters in the same way.
What does my RUNX1 result mean for my family?
A harmful change in the RUNX1 gene is usually passed down in families in a dominant way, so close relatives such as parents, brothers, sisters, and children may also carry the same change. In families with a RUNX1-related condition, relatives who carry it can have low platelets, easy bruising, or a higher chance of certain blood cancers. In some families, the change starts new in one person rather than being inherited from a parent.
Genetic information
Genetic testing
How you find out about variants
Variants in the RUNX1 gene are usually found with genetic testing for RUNX1 variants, using a blood sample or saliva sample. A lab reads the gene’s DNA code and may also check for missing or extra pieces, which can show whether a clinically important variant is present.
When should I consider getting a genetic test?
Consider RUNX1 testing if you or close relatives have lifelong low platelets, easy bruising or nosebleeds, or a family history of leukemia or related blood cancers. It can help explain an inherited bleeding tendency and clarify whether there is a higher inherited risk of certain blood cancers.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies with the condition and the type of variant involved. Lifestyle, environment, age, and medical history, among other factors, all help shape how the body functions over time. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most useful when considered together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug faster or slower than expected, so the same treatment may work differently from one person to another. These inherited differences are common and can influence how well a medicine works or how likely side effects are. This is one reason medication response is often more individual than it first appears.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how differences in genes affect the way people respond to medications. It looks at relationships between genes and drugs to help explain why the same treatment can work differently from one person to another. With many medicines, genes can influence how strong a drug’s effect is or how the body handles it. This information can support more informed and more individualized treatment choices. If you want to read more about this subject, you can learn more in the LearnHub.
Drugs influenced by the RUNX1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about medicines, side effects, or your health are best discussed with your doctor. Researchers are studying whether changes in the RUNX1 gene may affect how some blood cancer treatments work, but this is not part of routine care.
History
The RUNX1 gene came to medical attention through leukemia research in the late 20th century, when scientists found that chromosome swaps involving this gene were recurring in some blood cancers. It was first widely known as AML1, a name still seen in older papers. From these first observations, research expanded steadily. In the 1990s, researchers also linked inherited changes in the RUNX1 gene to families with lifelong low platelets and a higher chance of developing leukemia, which helped connect cancer genetics with inherited blood conditions. As naming systems became more consistent, AML1 was renamed RUNX1 as part of the RUNX gene family. This work made the RUNX1 gene an important landmark in the history of blood cancer genetics.